Put Options

10 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.31 - $2.69 $15,458 - $31,742
-11,800 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$1.95 - $3.89 $3,510 - $7,002
1,800 Added 18.0%
11,800 $20,000
Q4 2021

Feb 14, 2022

SELL
$3.81 - $6.16 $26,670 - $43,120
-7,000 Reduced 41.18%
10,000 $8,000
Q4 2020

Feb 16, 2021

BUY
$1.05 - $3.67 $17,850 - $62,390
17,000 New
17,000 $3,000
Q2 2020

Aug 10, 2020

SELL
$1.75 - $2.3 $19,250 - $25,299
-11,000 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$1.8 - $4.28 $296,460 - $704,916
-164,700 Reduced 93.74%
11,000 $31,000
Q4 2018

Feb 12, 2019

BUY
$6.15 - $10.51 $4,305 - $7,357
700 Added 0.4%
175,700 $588,000
Q3 2018

Nov 09, 2018

BUY
$10.32 - $13.06 $1.81 Million - $2.29 Million
175,000 New
175,000 $171,000
Q4 2017

Feb 09, 2018

SELL
$8.77 - $12.28 $2.35 Million - $3.29 Million
-267,900 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$12.17 - $16.3 $3.26 Million - $4.37 Million
267,900
267,900 $489,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.